NEA Management Company’s Genocea Biosciences, Inc. GNCA Stock Holding History

NEA Management Company’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,376,936	Closed	-$13M	–	59
2022 Q1	$13M	Hold	10,376,936	–	–	0.37%	36
2021 Q4	$12M	Hold	10,376,936	–	–	0.24%	42
2021 Q3	$19.9M	Hold	10,376,936	–	–	0.24%	37
2021 Q2	$24.3M	Hold	10,376,936	–	–	0.32%	39
2021 Q1	$28.1M	Hold	10,376,936	–	–	0.63%	34
2020 Q4	$25.1M	Hold	10,376,936	–	–	0.66%	28
2020 Q3	$23.8M	Buy	10,376,936 +3,151,260	+44%	+$8.27M	1.01%	26
2020 Q2	$16.6M	Hold	7,225,676	–	–	0.67%	26
2020 Q1	$12.4M	Hold	7,225,676	–	–	0.65%	25
2019 Q4	$15M	Hold	7,225,676	–	–	0.71%	24
2019 Q3	$21M	Hold	7,225,676	–	–	1.74%	18
2019 Q2	$28.3M	Buy	7,225,676 +2,857,142	+65%	+$14.9M	1.98%	18
2019 Q1	$20.6M	Buy	4,368,534 +1,243,534	+40%	+$6.15M	1.07%	23
2018 Q4	$7.17M	Hold	3,125,000	–	–	0.28%	34
2018 Q3	$19.5M	Hold	3,125,000	–	–	0.84%	28
2018 Q2	$21.3M	Hold	3,125,000	–	–	1%	22
2018 Q1	$26.3M	Buy	+3,125,000	New	+$26M	1.17%	21

Other funds holding GNCA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

NEA Management Company's GNCA Position: Q2 2022 in Review

NEA Management Company sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 10,376,936 shares — an estimated $13M sold.

NEA Management Company first reported a position in GNCA in Q1 2018 and held it in 17 quarters. The position peaked at $28.3M in Q2 2019. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

NEA Management Company reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
NEA Management Company sold 10,376,936 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $13M.
NEA Management Company first reported a position in Genocea Biosciences, Inc. in Q1 2018 and held it in 17 quarters.
NEA Management Company's Genocea Biosciences, Inc. position peaked at $28.3M in Q2 2019.
5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on NEA Management Company's 13F filing for Q2 2022, filed 15 Aug 2022.